OCV Partners

OCV Partners is a Los Angeles-based venture capital firm that specializes in growth-stage investments across the technology, healthcare, and life sciences sectors. Founded in 2016 by Richard Caruso and Mark Mitchell, the firm focuses on identifying companies with differentiated intellectual property and high barriers to entry. OCV provides both capital and strategic guidance to help its portfolio companies scale their operations and navigate complex regulatory landscapes. Within the healthcare domain, the firm has a strong track record of investing in innovative therapeutic platforms, medical devices, and digital health solutions. Notable investments include Prometheus Biosciences, which was later acquired by Merck, and Senti Bio, a leader in synthetic biology.